Muhammad Aamir Javed

Design, synthesis and bioevaluation of new vanillin hybrid as multitarget inhibitor of α-glucosidase, α-amylase, PTP-1B and DPP4 for the treatment of type-II diabetes

Mohammed Ayed Huneif, Dhafer Alshehri, Khaled S. Alshaibari et al. · Biomedicine & Pharmacotherapy · 2022 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Structural Modification, <i>In Vitro</i>, <i>In Vivo</i>, <i>Ex Vivo</i>, and <i>In Silico</i> Exploration of Pyrimidine and Pyrrolidine Cores for Targeting Enzymes Associated with Neuroinflammation and Cholinergic Deficit in Alzheimer’s Disease

Muhammad Aamir Javed, Nighat Ashraf, Muhammad Saeed Jan et al. · ACS Chemical Neuroscience · 2021 · 56 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Anti-Inflammatory, Analgesic and Antioxidant Potential of New (2S,3S)-2-(4-isopropylbenzyl)-2-methyl-4-nitro-3-phenylbutanals and Their Corresponding Carboxylic Acids through In Vitro, In Silico and In Vivo Studies

Fawad Mahmood, Jamshaid Ali Khan, Mater H. Mahnashi et al. · Molecules · 2022 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies

Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan et al. · RSC Advances · 2022 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Evaluation of pyrimidine/pyrrolidine-sertraline based hybrids as multitarget anti-Alzheimer agents: In-vitro, in-vivo, and computational studies

Muhammad Aamir Javed, Muhammad Saeed Jan, Abdullah M. Shbeer et al. · Biomedicine & Pharmacotherapy · 2023 · 26 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17